H3 K27M突变型弥漫性中线胶质瘤的软脑膜播散:临床特征、危险因素与预后分析
该研究纳入2017年10月17日至2023年10月17日诊断的304例H3 K27M突变型弥漫性中线胶质瘤患者,其中32例诊断为软脑膜播散。中位总生存期12.5个月,软脑膜播散后生存期8.0个月;对比增强病灶达室管膜(室管膜接触I型)是软脑膜播散的独立危险因素,放疗与术前KPS≥90与更长总生存期相关。
要点
- 304例H3 K27M突变型弥漫性中线胶质瘤中32例发生软脑膜播散,中位总生存期12.5个月。
- 对比增强病灶达室管膜(室管膜接触I型)是软脑膜播散的独立危险因素。
- 软脑膜播散后化疗是潜在治疗选择,幕上位置与软脑膜播散后化疗为软脑膜播散后生存期的独立有利预后因素。
核心结论
- 对比增强病灶与脑室受累的关联是H3 K27M突变型弥漫性中线胶质瘤患者软脑膜播散的独立预测因素。
- 放疗和术前KPS可能有助于改善这些患者的总生存期。
- 化疗是软脑膜播散诊断后的潜在治疗选择。
研究设计与样本
- 研究纳入2017年10月17日至2023年10月17日诊断的304例H3 K27M突变型弥漫性中线胶质瘤患者,其中32例诊断为软脑膜播散。
- 采用逻辑回归分析识别软脑膜播散的预测因素,包括临床、分子和影像数据。
- 采用单变量和多变量Cox回归分析总生存期和软脑膜播散后生存期。
主要发现
- 中位总生存期为12.5个月,中位软脑膜播散后生存期为8.0个月。
- 对比增强病灶达室管膜(室管膜接触I型)是软脑膜播散的唯一独立危险因素。
- 男性和室管膜接触I型是原发性软脑膜播散的独立危险因素。
- 在所有软脑膜播散患者中,KPS≥90和放疗与更长总生存期统计学显著相关,原发性软脑膜播散与更短总生存期显著相关。
- 幕上位置和软脑膜播散诊断后化疗是软脑膜播散后生存期的独立有利预后因素;在原发性软脑膜播散亚组分析中,放疗是总生存期唯一独立有利预后因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to describe the incidence, clinical and pathological features, and outcomes of H3 K27M- mutant Diffuse Midline Glioma (DMG) patients with leptomeningeal dissemination (LMD) and systematically investigate the predictive and prognostic factors to clarify the response to treatment after the onset of LMD. METHODS: A total of 304 patients diagnosed with DMG from October 17, 2017, to October 17, 2023, were enrolled in this study, of which 32 patients were diagnosed with LMD. Logistic regression analyses were conducted to identify the predictors of LMD, including clinical, molecular, and imaging data. Univariable and multivariable cox regression analyses were used for overall survival (OS) and post-LMD survival (PLS) analysis. RESULTS: The median OS and PLS were 12.5 and 8.0 months respectively. Tumor with contrast-enhanced lesions reaching ependyma (Ventricular contact type I) was the only independent risk factor for LMD. Male sex and ventricular contact type I were independent risk factors for primary LMD. In all LMD patients, Karnofsky Performance Status (KPS) of ≥ 90 and radiotherapy were statistically significantly associated with longer OS, and primary LMD was significantly associated with shorter OS. Supratentorial location and chemotherapy after LMD diagnosis were independent favorable prognostic factors on PLS. In primary LMD subgroup analysis, radiotherapy was the only independent favorable prognostic factor on OS. CONCLUSIONS: The association between contrast-enhanced lesions and ventricular involvement is an independent predictive factor for LMD in DMG patients. Radiotherapy and preoperative KPS may contribute to improved overall survival in these patients. Chemotherapy is a potential treatment option following an LMD diagnosis.
引用
- Zhong S, Zuo J, Fu X, et al. Leptomeningeal dissemination in H3 K27M- mutant diffuse midline gliomas: clinical characteristics, risk factors, and prognostic insights. J Neurooncol. 2025. PMID: 39812935. doi:10.1007/s11060-024-04933-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。